Diagnostic Assay Development
Dx assays has extensive expertise and target class to develop nucleic acid based detection and quantification assays according to client specifications.
A key part of our customized assay development service is the direct interaction with our dedicated scientists, from the start to the successful completion of the project.
The pipeline of assay development in Dx assays includes:
- Design and Feasibility Studies, which is crucial for decision making and assay development
- Primer/probe design and optimization
- Chemistry optimization
- Guard banding
- Proof-of-concept studies
- Design and Development planning
- Design Transfer
- Provision of sample preparation and assay protocols
- Provision of R&D manufacturing lots
Our experiences include the development of disease relevant assays for liver diseases (e.g. HAV), veterinary diseases (e.g. blue tongue virus, Taylorella)
and renal diseases (e.g. BKV).